Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.97 USD | +0.73% | +12.02% | -13.05% |
Financials (USD)
Sales 2024 * | 123M | Sales 2025 * | 186M | Capitalization | 2.44B |
---|---|---|---|---|---|
Net income 2024 * | -275M | Net income 2025 * | -159M | EV / Sales 2024 * | 17.6 x |
Net cash position 2024 * | 262M | Net cash position 2025 * | 225M | EV / Sales 2025 * | 11.9 x |
P/E ratio 2024 * |
-9.01
x | P/E ratio 2025 * |
-16.4
x | Employees | 226 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.1% |
Latest transcript on Rhythm Pharmaceuticals, Inc.
1 day | +0.73% | ||
1 week | +12.02% | ||
Current month | +12.02% | ||
1 month | +1.58% | ||
3 months | -4.08% | ||
6 months | +5.18% | ||
Current year | -13.05% |
Managers | Title | Age | Since |
---|---|---|---|
David Meeker
CEO | Chief Executive Officer | 69 | 15-10-31 |
Hunter Smith
DFI | Director of Finance/CFO | 56 | 17-06-30 |
Joseph Shulman
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christophe Jean
BRD | Director/Board Member | 67 | 15-03-31 |
Jennifer Good
BRD | Director/Board Member | 59 | 19-06-18 |
David McGirr
BRD | Director/Board Member | 69 | 15-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.09% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 39.97 | +0.73% | 466,405 |
24-06-06 | 39.68 | -0.60% | 441,118 |
24-06-05 | 39.92 | +3.47% | 716,941 |
24-06-04 | 38.58 | +1.93% | 472,997 |
24-06-03 | 37.85 | +6.08% | 641,574 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.05% | 2.44B | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- RYTM Stock